Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Proteon Therapeutics logo — Pioneering medical advancements to improve renal and vascula...

Proteon Therapeutics

Pioneering medical advancements to improve renal and vascular health through innovative tissue remodeling techniques.

Founded 2001 Post Ipo Equity Total: $188.54M Biotechnology, Pharmaceutical

General Information

Company Name Proteon Therapeutics
Founded Year 2001
Industries Biotechnology, Pharmaceutical
Funding Stage Post Ipo Equity
Social

Get notified when Proteon Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Proteon Therapeutics

Proteon Therapeutics, Inc is a biopharmaceutical company founded in 2001, pioneering medical advancements to improve renal and vascular health through innovative tissue remodeling techniques. The company is focused on developing pharmaceuticals for patients with renal and vascular diseases. Proteon Therapeutics leverages a unique understanding of tissue remodeling to build a pipeline of proprietary therapeutics. Their first drug candidate, PRT-201, aims to improve blood flow following vascular surgery procedures. The company's clinical efforts are initially concentrated on vascular access for hemodialysis and peripheral arterial disease (PAD). Proteon Therapeutics recently secured a €21.00M Post-IPO Equity investment on 10 August 2021, with funding from Seventure Partners, Aqua-Spark, Montis Capital, LLC, PFR Life Science, and Nutreco. As the company remains at the forefront of biotechnological advancements in the Biotechnology and Pharmaceutical industries, this investment will likely further propel their research and development efforts, positioning Proteon Therapeutics to make significant contributions to the advancement of medical treatments for renal and vascular diseases.

Taxonomy: biopharmaceutical, renal disease, vascular disease, tissue remodeling, proprietary therapeutics, drug development, PRT-201, vascular surgery, hemodialysis, peripheral arterial disease (PAD)

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 5
Investor Investor Investor
•••• •••• 		10 Aug 2021
Grant •••••• - 25 Jul 2019
Post-IPO Equity •••••• 1 •••• •••• 22 Jun 2017
Series D •••••• 10
Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		16 May 2014
Venture Round •••••• - 19 Feb 2014

View All 9 Funding Rounds

Proteon Therapeutics Alternatives & Competitors

Proteon Therapeutics vs
ImaRX Therapeutics
ImaRX Therapeutics

Discover novel therapies for vascular disorders with advanced micro bubble technology.

Series Unknown
Biotechnology, Health Care
Proteon Therapeutics vs
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Canada

Biopharmaceutical leaders developing the next generation of medicine to normalize host vascular resp...

Grant
10 employees
Biotechnology, Health Care
Proteon Therapeutics vs
Micro Therapeutics
Micro Therapeutics

Innovative solutions for neurovascular and peripheral vascular disease treatment.

Health Care, Health and Wellness

FAQ About Proteon Therapeutics

Pioneering medical advancements to improve renal and vascular health through innovative tissue remodeling techniques.
Proteon Therapeutics was founded in 2001.
Proteon Therapeutics operates in the following industries: Biotechnology, Pharmaceutical.
Proteon Therapeutics has completed 9 funding rounds, raising a total of $188.54M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Proteon Therapeutics include ImaRX Therapeutics, Vasomune Therapeutics, Inc., Micro Therapeutics, Pacific Vascular, Inc., Intact Vascular. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Proteon Therapeutics and ImaRX Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Proteon Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy